Riociguat
As part of our commitment to advancing knowledge and awareness of pulmonary hypertension, we invite you to explore our collection of videos and graphics that further illustrate and discuss our recent journal publications.
Author VLOG: Sandeep Sahay and Franck Rahaghi - Riociguat combination therapies in PAH
Dr Sahay and Dr Rahaghi discuss the role of riociguat in combination therapy in PAH
Author VLOG: Bryan Kelly and Victor Moles - Michigan Multicenter CTEPH Collaboration: multidisciplinary management of CTEPH
Dr Kelly and Dr Moles discuss the Michigan CTEPH collaboration programme
Author VLOG: Raymond Benza - Effects of riociguat on the right ventricle
Professor Benza discusses the effect of riociguat on the right ventricle in PAH and CTEPH
Author VLOG: Stephan Rosenkranz - Application of the COMPERA 2.0 risk score to the REPLACE study
Professor Rosenkranz discusses the application of the COMPERA 2.0 risk score in REPLACE
Author VLOG: Raymond Benza - Application of the REVEAL Lite 2 risk score to the REPLACE study
Professor Benza discusses the application of the REVEAL Lite 2 risk score in REPLACE
PATENT-CHILD animated abstract - Riociguat in children with PAH
Animated summary of the PATENT-CHILD study of riociguat in children with PAH
Copyright © 2025 Bayer AG and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
This website is maintained by Adelphi Communications Ltd, Bollington, UK
MA-M_RIO-ALL-0352-1
Bayer AG, Pharmaceuticals
13353 Berlin,
Germany
Phone: +49 30 468 11 11
Merck Sharp & Dohme Corp.,
a subsidiary of Merck & Co
2000 Galloping Hill Road
Kenilworth, NJ 07033 U.S.A.
Phone: +1 908 740 4000
Copyright © 2025 - All Rights Reserved